SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-054770
Filing Date
2007-03-15
Accepted
2007-03-14 19:34:36
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR CORTEX PHARMACEUTICALS, INC. d10k.htm 10-K 910227
2 LEAVE OF ABSENCE AGREEMENT DATED JANUARY 4, 2007 dex1099.htm EX-10.99 15693
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 1033
4 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1568
5 CONSENT OF HASKELL & WHITE LLP dex232.htm EX-23.2 1984
6 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9810
7 SECTION 302 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9793
8 SECTION 906 CERTIFICATION OF THE CEO AND CFO dex32.htm EX-32 4636
9 GRAPHIC g25669img001.jpg GRAPHIC 53671
  Complete submission text file 0001193125-07-054770.txt   1030227
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 07694778
SIC: 2834 Pharmaceutical Preparations